´óÊóÒÒõ£µ¨¼îõ¥Ã¸(AChE)elisaÊÔ¼ÁºÐѯ¼Û

ÐͺÅ:

´óÊóÐØÏٻµ÷½ÚÇ÷»¯Òò×Ó(TARC/CCL17)elisaÊÔ¼ÁºÐѯ¼Û

ÐͺÅ:

´óÊóÈÈÐݿ˵°°×47(HSP47)elisaÊÔ¼ÁºÐѯ¼Û

ÐͺÅ:

´óÊóÌÇȱʧÐÔתÌúµ°°×(CDT)elisaÊÔ¼ÁºÐѯ¼Û

ÐͺÅ:

»Ç°·Ê®ÎåºÏÒ»£¨SAs£©¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

´óÊó×éÖ¯ÐÍÏËάÈÜø¼¤»î¼Á(t-PA)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

´óÊó×ܵ¨¹Ì´¼£¨TC£©¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

´óÊóת»¯Éú³¤Òò×Ó£¨TGF£© ÃâÒß×黯¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

´óÊóÖ¬·¾ËáºÏ³Éø£¨FAS£©¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

´óÊóµÍÑõÓÕµ¼Òò×Ó-1¦Á(HIF-1¦Á)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó°×½éËØ11(IL-11)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¾ÞÊÉϸ°ûÑ×ÐÔµ°°×1¦Â(MIP-1¦Â/CCL4)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó°×½éËØ15(IL-15)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¾ÞÊÉϸ°ûÑ×ÐÔµ°°×3¦Á(MIP-3¦Á/CCL20)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó¦Ã¸ÉÈÅËØ(IFN-¦Ã)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó17ôÇƤÖÊÀà¹Ì´¼(17-OHCS)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó»ùÖʽðÊôµ°°×ø2/Ã÷½ºÃ¸A(MMP-2/Gelatinase A)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóÒȵºËØÑùÉú³¤Òò×Ó2(IGF-2)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊó°×½éËØ1¦Á(IL-1¦Á)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ:

СÊóÑÌõ£°·ÏÙàÑßʶþºËÜÕËáÁ×Ëá(NADPH)¼ì²âÊÔ¼ÁºÐ

ÐͺÅ: